| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/01/2001 | US6225312 Piperazine and piperidine compounds |
| 05/01/2001 | US6225311 Acetylenic α-amino acid-based sulfonamide hydroxamic acid tace inhibitors |
| 05/01/2001 | US6225309 Aminoheterocyclic derivatives as antithrombotic or anticoagulant agents |
| 05/01/2001 | US6225308 Tissue selective compounds in the treatment of prostate cancer or benign prostate hypertrophy |
| 05/01/2001 | US6225307 Caprolactam-phenyl phenylcarbamate |
| 05/01/2001 | US6225305 Substituted urea and isothiorea derivatives as no synthase inhibitors |
| 05/01/2001 | US6225304 Dry solid mixture of an amoxicillin and a hydroxy-polycarboxylic acid |
| 05/01/2001 | US6225302 Amidino protease inhibitors |
| 05/01/2001 | US6225301 Particularly using the isozyme selective pkc inhibitor, (s)-3,4-(n, n'-1,1'-((2?-ethoxy)-3'?(o)-4'?-(n,n-dimethylamino)-butane)-bi s-(3, 3'-indolyl) )-1(h)-pyrrole-2,5-dione hydrochloride salt |
| 05/01/2001 | US6225300 TNF receptor and steroid hormone in a combined therapy |
| 05/01/2001 | US6225299 Especially seborrhea, acne vulgaris, androgenically conditioned alopecia and androgenic symptoms of women. |
| 05/01/2001 | US6225298 Compositions and methods for contraception and for treatment of benign gynecological disorders |
| 05/01/2001 | US6225297 Combination contraceptive |
| 05/01/2001 | US6225295 Method of treating acetaminophen overdose |
| 05/01/2001 | US6225294 Oral administration of bisphosphonate on continuous dosing schedule for prevention of bone disorders, while minimizing the occurrence of or potential for adverse gastrointestinal effects |
| 05/01/2001 | US6225292 Inhibitors of DNA immunostimulatory sequence activity |
| 05/01/2001 | US6225291 Rod opsin mRNA-specific ribozyme compositions and methods for the treatment of retinal diseases |
| 05/01/2001 | US6225102 Amino acid sequence of guanosine triphosphatase from streptococcus; diagnosis; prophylaxis; drug screening; bactericides; bacteriostats |
| 05/01/2001 | US6225098 UDP-N-acetylenolpyruvyglucosamine reductase |
| 05/01/2001 | US6225087 Polynucleotide which codes for a polypeptide of defined amino acid sequence; drug screening of bactericides against streptococcus; otitis media; conjunctivitis; pneumonia; meningitis; sinusitis; pleural empyema; endocarditis |
| 05/01/2001 | US6225085 Nucleotide and amino acid sequence of leucine-rich surface glycoprotein; diagnosis; prophylaxis; therapy; drug screening; fusion proteins; antigenic peptides; antibodies; recombinant production |
| 05/01/2001 | US6225084 Nucleotide and amion acid sequence of genes that are up-regulated in endothelial cells subjected to shear stress; atherosclerosis, antiischemic agents; hypotensive agents; restenosis; antiinflammatory agents for arteries |
| 05/01/2001 | US6224910 Method for the preparation of an enteric coated high drug load pharmaceutical composition |
| 05/01/2001 | US6224909 Fast decomposing pellets |
| 05/01/2001 | US6224907 Anti-asthma therapy |
| 05/01/2001 | US6224905 Porous matrix network |
| 05/01/2001 | US6224902 Mixture of delivery vehicle and sterol |
| 05/01/2001 | US6224901 Method for delivering beneficial compositions to hair follicles |
| 05/01/2001 | US6224899 Adhesive cooling composition and process for its preparation |
| 05/01/2001 | US6224897 Applying transdermal nicotine patch |
| 05/01/2001 | US6224895 Administering domperidone |
| 05/01/2001 | US6224891 Compounds and methods for the treatment of bacterial dysentery using antibiotics and toxin binding oligosaccharide compositions |
| 05/01/2001 | US6224887 Antifungal nail lacquer and method using same |
| 05/01/2001 | US6224885 Barrier cream comprising hexamethylenetetramine or derivative thereof |
| 05/01/2001 | US6224883 Supplying to tumor, cancer |
| 05/01/2001 | US6224881 DNA molecule fragments encoding for cellular uptake of Mycobacterium tuberculosis and uses thereof |
| 05/01/2001 | US6224873 Regulation of appetite, body weight and athletic function with materials derived from citrus varieties |
| 05/01/2001 | US6224870 Administering a nucleic acid |
| 05/01/2001 | US6224869 Isolated polypeptide |
| 05/01/2001 | US6224862 Mixture of prothrombinase and protein; anticoagulant |
| 05/01/2001 | US6224861 Polypeptide |
| 05/01/2001 | US6224857 Pharmaceutical preparations comprised of salts of hyaluronic acid with local anaesthetics |
| 05/01/2001 | US6224850 Antiwrinkle cosmetic/pharmaceutical compositions comprising iridaceae extracts |
| 05/01/2001 | US6224849 Alkylaminobenzothiazole and-benzoxazole derivatives |
| 05/01/2001 | US6224847 Using 1,1,1,2-tetrafluoroethane and cosolvent of alkane or hydrocarbon ether |
| 05/01/2001 | US6224717 Methods for separating a tocotrienol from a tocol-containing mixture and compositions thereof |
| 05/01/2001 | CA2268703C Enantiomerically pure .beta.-d-dioxolane nucleosides with selective anti-hepatitis b virus activity |
| 05/01/2001 | CA2210875C Cationic copolymers of vinylamine and vinyl alcohol for the delivery of oligonucleotides |
| 05/01/2001 | CA2203464C Antimycotic ectoparasiticidal product - external use |
| 05/01/2001 | CA2197178C Bicyclolactam compounds, use of the same and intermediate in the production of the same |
| 05/01/2001 | CA2186919C Therapeutic anti-inflammatory and analgesic pharmaceutical composition containing nimesulide 4-nitro, 2 phenoxyphenyl methane sulphonamide for use transdermally and a process for the manufacture thereof |
| 05/01/2001 | CA2139169C Antiherpes peptidomimetic compounds |
| 05/01/2001 | CA2121473C Methods and compositions for treating allergic reactions |
| 05/01/2001 | CA2111169C Phenylacetic acid derivatives, process for the preparation thereof and corresponding use |
| 05/01/2001 | CA2088665C Methotrexate derivative |
| 05/01/2001 | CA2088376C Dosage form for time-varying patterns of drug delivery |
| 05/01/2001 | CA2048856C 15-deoxyspergualin suppository |
| 05/01/2001 | CA2034926C Treatment of poisoning and compositions for use therein |
| 05/01/2001 | CA2016664C Indole derivative and method of production thereof |
| 05/01/2001 | CA2001265C Analogs of peptidase substrates |
| 05/01/2001 | CA2001264C 3.beta.,17.beta.-hydroxy-substituted steroids and related steroidal compounds |
| 05/01/2001 | CA1341226C Gene replacement as a tool for the construction of aspergillus strains |
| 04/29/2001 | CA2325069A1 Use of corticotropin releasing factor antagonists and related compositions |
| 04/29/2001 | CA2324640A1 Method for preparing sodium-hydrogen exchanger type 1 inhibitor |
| 04/29/2001 | CA2322903A1 Treatment, diagnosis and evaluation of anti-cancer therapy resistance in melanoma |
| 04/29/2001 | CA2286401A1 Methods of diagnosing and treating melanoma utilizing tyrp2 |
| 04/28/2001 | CA2324495A1 New 9-(3,5-dimethoxyphenyl)-5,8,8a,9-tetrahydrofuro ¢3',4':6,7!-naphto ¢2,3-d! ¢1,3! dioxol-6(5ah)-one derivatives, their preparation process and pharmaceutical compositions containing them |
| 04/27/2001 | CA2324538A1 Gastric acid secretion |
| 04/26/2001 | WO2001029315A1 Tissue products containing antiviral agents which are mild to the skin |
| 04/26/2001 | WO2001029219A1 Human cub-domain-containing protein and gene encoding the same |
| 04/26/2001 | WO2001029218A2 Nuclear matrix proteins, polynucleotide sequences encoding them, and their use |
| 04/26/2001 | WO2001029209A1 Preparation of cellular components that are substantially free of chromosomal dna |
| 04/26/2001 | WO2001029178A2 Epo primary response gene 1, eprg1 |
| 04/26/2001 | WO2001029084A2 Novel human proteins and polynucleotides encoding the same |
| 04/26/2001 | WO2001029073A1 Methods for improving secondary metabolite production in fungi |
| 04/26/2001 | WO2001029071A2 Genes associated with obesity and methods for using the same |
| 04/26/2001 | WO2001029070A2 Modulation of t cell differentiation for the treatment of t helper cell mediated diseases |
| 04/26/2001 | WO2001029061A1 Novel fusidic acid derivatives |
| 04/26/2001 | WO2001029057A1 Antisense modulation of bcl-6 expression |
| 04/26/2001 | WO2001029056A1 Tadg-15: an extracellular serine protease overexpressed in carcinomas |
| 04/26/2001 | WO2001029055A2 Novel oligosaccharides, preparation method and pharmaceutical compositions containing same |
| 04/26/2001 | WO2001029054A2 Medicaments for treatment of respiratory syncytial virus infections |
| 04/26/2001 | WO2001029049A2 Imidazole derivatives as phosphodiesterase vii inhibitors |
| 04/26/2001 | WO2001029046A2 A salt of morphine |
| 04/26/2001 | WO2001029044A1 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 04/26/2001 | WO2001029042A1 Heteroalkylamino-substituted bicyclic nitrogen heterocycles as inhibitors of p38 protein kinase |
| 04/26/2001 | WO2001029041A1 Alkylamino substituted bicyclic nitrogen heterocycles as inhibitors of p38 protein kinase |
| 04/26/2001 | WO2001029039A1 Synthesis and methods of use of 9-substituted guanine derivatives |
| 04/26/2001 | WO2001029038A1 Tricyclic fused-imidazole derivatives |
| 04/26/2001 | WO2001029037A2 Condensed naphthyridines as hiv reverse transcriptase inhibitors |
| 04/26/2001 | WO2001029036A2 Allosteric sites on muscarinic receptors |
| 04/26/2001 | WO2001029035A1 4-oxoquinolizine antimicrobials having 2-pyridone skeletons as the partial structure |
| 04/26/2001 | WO2001029034A1 Quinuclidine acrylamides |
| 04/26/2001 | WO2001029031A1 Process for the preparation of paroxetine |
| 04/26/2001 | WO2001029030A1 N-substituted 1-(lactone) isoquinolones for treating nervous disorders |
| 04/26/2001 | WO2001029029A1 Tetrahydrobenzindolone derivatives, their preparation and their use as 5-ht7 receptor antagonists |
| 04/26/2001 | WO2001029028A1 9- (piperazinylalkyl) carbazoles as bax-modulators |
| 04/26/2001 | WO2001029027A1 2-alkoxybenzene derivatives |
| 04/26/2001 | WO2001029026A1 Phenyl- and pyridyl-tetrahydro-pyridines having tnf inhibiting activity |
| 04/26/2001 | WO2001029025A2 Tyrosine kinase inhibitors |